Inmode (INMD) reported $370M in revenue for fiscal 2025, −6.2% year on year. That ranks #2391 by revenue among 2853 SEC filers and #237 in Healthcare. Net income was $93.8M, a net margin of 25.3%. Revenue has grown 27.4% a year on average since 2017 ($53.5M then). The fiscal 2025 balance sheet shows $766M in total assets and $303M in cash.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $370M | −6.2% | FY20252025-12-31 |
| Gross profitGrossProfit | $291M | −8.2% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $85.4M | −24.1% | FY20252025-12-31 |
| Net incomeProfitLoss | $93.8M | −48.2% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $85.3M | −35.7% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $972,000 | +45.3% | FY20252025-12-31 |
| Total assetsAssets | $766M | −2.4% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $683M | −2.9% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $303M | +94.8% | FY20252025-12-31 |
| Long-term debt | Not reported | — |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Profile
- Legal name
- Inmode Ltd.
- Ticker
- INMD
- Exchange
- Nasdaq
- SIC classification
- Electromedical & Electrotherapeutic Apparatus (3845)
- Fiscal year end
- 12-31
- CIK
- 0001742692
Filings
- 20-FFeb 10, 2026Open filing →
- 20-FFeb 4, 2025Open filing →
- 20-FFeb 13, 2024Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Twist BioscienceTWST | $377M | −$77.7M |
| Pharming GroupPHAR | $376M | $2.9M |
| Arcutis BiotherapeuticsARQT | $376M | −$16.1M |
| InmodeINMD | $370M | $93.8M |
| MannkindMNKD | $349M | $5.9M |
| InogenINGN | $349M | $22.7M |
| Castle BiosciencesCSTL | $344M | −$24.2M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Inmode — Key figures |url=https://companiesranked.com/en/company/inmode |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Inmode — Key figures. CompaniesRanked. https://companiesranked.com/en/company/inmodeBibTeX
@misc{companiesranked-en-company-inmode-2026,
author = {{CompaniesRanked}},
title = {{Inmode — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/inmode}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001178913-26-000377 · February 10, 2026
{{cite web |title=Inmode — Key figures — 20-F (0001178913-26-000377) |url=https://www.sec.gov/Archives/edgar/data/1742692/000117891326000377/zk2634286.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.